Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells.
about
Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular CarcinomaEthylacetate extract from Tetrastigma hemsleyanum induces apoptosis via the mitochondrial caspase-dependent intrinsic pathway in HepG2 cells.Quercetin and Cisplatin combined treatment altered cell cycle and mitogen activated protein kinase expressions in malignant mesotelioma cells.HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma.Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinomaThe pleiotropic flavonoid quercetin: from its metabolism to the inhibition of protein kinases in chronic lymphocytic leukemia.Differential impact of flavonoids on redox modulation, bioenergetics and cell signalling in normal and tumor cells: a comprehensive review.Dual properties of hispidulin: antiproliferative effects on HepG2 cancer cells and selective inhibition of ABCG2 transport activity.RGD peptide targeted lipid coated nanoparticles for combinatorial delivery of sorafenib and quercetin against hepatocellular carcinoma.Synergistic Anticancer Activities of Natural Substances in Human Hepatocellular Carcinoma.Nephrotoxicity Induced by Cisplatin Intake in Experimental Rats and Therapeutic Approach of Using Mesenchymal Stem Cells and Spironolactone.Induction of S phase arrest and apoptosis by ethyl acetate extract from Tetrastigma hemsleyanum in human hepatoma HepG2 cells.
P2860
Q26767372-6EE5CA41-446E-4E0F-82A1-2F7FC6886A76Q35740494-5F510C8D-EFE1-4846-B421-1676522FEB34Q36101738-0E6CC496-0DA7-42A9-AF5C-412E09C93E8AQ36545292-0772C5B8-26FA-4BC6-8C57-F6DCF2413FBEQ37031730-4745D3BC-2BE3-4E04-B69C-9DAE0BF5444AQ38237264-872E4D42-FC8D-45A5-8A25-397E6490E570Q38616035-2797EF08-B297-4F17-A91E-A294AFCD8B1AQ38849522-E9BCFC5C-3B0D-4878-8AB1-6BD083DAEABFQ40688909-5FC601FE-1D64-496B-ADC5-809423AE6F8FQ42343450-91EF7703-300B-459C-B6B3-DA8436A4FC31Q50086407-79FD7AA7-7ADF-45D3-9CD1-D60E4F0D99D4Q52974942-935837AD-285A-4751-85BC-26CCFA391669
P2860
Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Synergistic growth-suppressive ...... epatocellular carcinoma cells.
@en
Synergistic growth-suppressive ...... epatocellular carcinoma cells.
@nl
type
label
Synergistic growth-suppressive ...... epatocellular carcinoma cells.
@en
Synergistic growth-suppressive ...... epatocellular carcinoma cells.
@nl
prefLabel
Synergistic growth-suppressive ...... epatocellular carcinoma cells.
@en
Synergistic growth-suppressive ...... epatocellular carcinoma cells.
@nl
P2093
P2860
P1476
Synergistic growth-suppressive ...... epatocellular carcinoma cells.
@en
P2093
Hong-jun Jiao
Ji-ling Zhao
P2860
P2888
P304
P356
10.1007/S12010-013-0561-Z
P577
2014-01-01T00:00:00Z